Intrasense Delays 2026 Half-Year Results Publication

Intrasense, a French company specializing in AI-driven medical imaging solutions, announced a delay in the release of its 2026 half-year results and financial report. Originally planned for September 15, 2026, the publication is now rescheduled for September 28, 2026, after market close. This adjustment in timing is due to changes in the schedule of the Guerbet Group.

Intrasense has been a notable player in medical imaging since 2004 and became part of the Guerbet Group in 2023. The company offers advanced platforms like Myrian®, DUOnco™, and Liflow®, each enhancing the diagnosis and monitoring of various medical conditions through artificial intelligence.